Lates News

Every AI's flash news, Cinda Securities announced on March 24th that it has given Baiyunshan (600332.SH) a "buy" rating in its research report. The main reasons for the rating include: 1) outstanding performance on the income side & pressure on pharmaceutical products, short-term pressure on 25Q4 quarterly profits; 2) comprehensive deployment of "internationalization + research and development innovation + external development + market value management". (Daily Economic News)